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Abstract
Objective: Visceral fat (VF) increases cardiometabolic risk more than fat stored subcutaneously. Here, we
investigated how well routine clinical measures of adiposity, namely body mass index (BMI) and waist circumference
(waist), predict VF and subcutaneous fat (SF) in a large population-based sample of adolescents. As body-fat
distribution differs between males and females, we performed these analyses separately in each sex.
Design and Methods: VF and SF were measured by magnetic resonance imaging in 1,002 adolescents (482 males,
age 12–18 years). Relationships of BMI and waist with VF and SF were tested in multivariable analyses, which
adjusted for potentially confounding effects of age and height.
Results: In both males and females, BMI and waist were highly correlated with VF and SF, and explained 55–76% of
their total variance. When VF was adjusted for SF, however, BMI and waist explained, respectively, only 0% and 4%
of VF variance in males, and 4% and 11% of VF variance in females. In contrast, when SF was adjusted for VF, BMI
and waist explained, respectively, 36% and 21% of SF variance in males, and 48% and 23% of SF variance in
females. These relationships were similar during early and late puberty.
Conclusions and Relevance: During adolescence, routine clinical measures of adiposity predict well SF but not VF.
This holds for both sexes and throughout puberty. Further longitudinal studies are required to assess how well these
measures predict changes of VF and SF over time. Given the clinical importance of VF, development of cost-effective
imaging techniques and/or robust biomarkers of VF accumulation that would be suitable in everyday clinical practice
is warranted.
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Introduction
Obesity is a major public health problem [1,2]. Due to its
currently high prevalence and adverse effects on health [1,2],
our life expectancy has been projected to decline for the first
time since the Great Depression [3]. This is in part due to
obesity increasing significantly risk for cardio-metabolic
diseases (CMD), such as cardiovascular disease and type-2
diabetes mellitus [2,4], which in turn are the major causes of
morbidity and mortality in the industrialized world. This obesity-
related risk for CMD is mainly the consequence of adipose
tissue releasing a number of adipocytokines that, once
released into the circulation, promote the development of CMD
[5].
The relationship between obesity and CMD is not simple,
however. About 30% of adult individuals who are classified as
“obese” are cardiometabolically healthy and over 20% who are
classified as being of “normal weight” are cardiometabolically
abnormal [6]. To some extent, this may be an artefact of the
measurement method. For over 150 years, obesity has been
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assessed with body mass index (BMI, weight/height2), which is
an imprecise, and possibly misleading [7], metric of body fat.
This is because BMI (and waist circumference [waist]) are
influenced not only by fat mass but also by muscle mass and
bone mass, among others [8].
Further, obesity-related risk for CMD increases not only with
the quantity but also with a specific distribution of body fat –
individuals who store body fat viscerally rather than elsewhere
in the body (mostly subcutaneously) are at a greater risk for
CMD [9–11]. This relationship is seen not only in adults, but
also in children and adolescents [12–16]. Several mechanistic
pathways have been proposed to underlie the link between
visceral fat (VF) and CMD - VF, as compared with
subcutaneous fat (SF), exhibits a more adverse secretory
profile and higher lipid turnover [4,17–19]. Further, VF but not
SF drains directly to the portal circulation and liver, where it
enhances dyslipidemia and insulin resistance, key mediators of
the link between obesity and CMD [4,20,21]. Consistent with
these differences between VF and SF, it has been
demonstrated that surgical removal of VF but not that of SF
improves cardio-metabolic health in humans and experimental
animals [22–24]. Moreover, a growing body of research
suggests that SF may even be cardiometabolically protective in
overweight and obesity [14,25,26]. This effect has been related
to the so-called “expandability” of SF, which is thought to be a
biological property of SF that allows excess body-fat to
accumulate preferentially in this fat depot and thus protects the
body from the cardiometabolically adverse accumulation of VF
[27,28].
Thus, given the biological and clinical differences between
VF and SF and hence the importance of quantifying them
separately, the aim of the present study was to investigate how
well routine clinical measures of adiposity, namely BMI and
waist, predict VF and SF measured directly with magnetic
resonance imaging (MRI) in a large population-based sample
of adolescents (n=1,002). We focused here on adolescence, as
it is an understudied period of human development [29] during
which the initial stages of CMD may emerge [13,30–34].
Methods
Adolescent sample
The study sample consisted of White Caucasian males
(n=482) and females (n=520), aged 12 to 18 years, who were
recruited via high schools from the Saguenay-Lac St. Jean
region of Quebec, Canada, as part of the Saguenay Youth
Study (SYS) [35]. The SYS is a population-based cross-
sectional study of cardio-metabolic and mental health during
adolescence. Assent of the adolescents and written consent of
the parents were obtained before data collection, and the
Research Ethics Committees of the Chicoutimi Hospital
(Chicoutimi, Canada) and the Hospital for Sick Children
(Toronto, Canada) approved the study. The current sample of
1,002 adolescents was recruited and tested between
November 2003 and February 2012.
Routine clinical measures of adiposity
Height (0.1-cm precision), weight (0.1-kg precision), waist
(0.1-cm precision), hip circumference (0.1-cm precision), and
suprailiac skinfold-thickness (suprailiac skinfold, 1-mm
precision) were measured by trained staff using standard
operating procedures [35]. Waist was measured at the level of
the natural waist, which is the narrowest part of the torso, as
seen from the anterior aspect. Hip circumference was
measured at the level of the maximum extension of the
buttocks. Suprailiac skinfold was measured in the midaxillary
line immediately superior to the iliac crest. BMI was calculated
as weight (in kg) divided by height (in m) squared. Waist to hip
ratio (waist/hip) was calculated as waist (in cm) divided by hip
circumference (in cm).
Magnetic resonance imaging of abdominal VF and SF
VF and SF were quantified with MRI from axial, 10-mm thick
(with in-plane resolution 1.56 x 1.56 mm2), heavily T1-
weighted, spin-echo (TR/TE = 200 ms/20 ms) scans, which
were taken along the abdomen with a Phillips 1.0-T magnetic
resonance scanner. A single slice at the level of the umbilicus
was used to quantify VF and SF. The single slice images were
smoothed using an adaptive bilateral filter to remove image
noise while preserving edge information. A standard region
growing algorithm written in MatLab (R2011a, MathWorks,
Natick, MA) was used to obtain an initial fat classification map.
An iterative refinement procedure corrected false positives and
negatives using morphological operators, including hysteresis,
thresholding over small neighbourhoods, and median filtering
to remove salt-and-pepper noise. The resultant image was
manually segmented into SF and VF using Adobe Photoshop
(CS5, Adobe Systems Incorporated, San Jose, CA). SF was
defined as the area of adipose tissue between the skin and the
outer aspect of abdominal musculature. VF was defined as the
as the area of adipose tissue within the inner aspect of
abdominal musculature and outside of abdominal organs. A
histogram counting algorithm written in MatLab (R2011a,
MathWorks, Natick, MA) computed the total number of pixels
for each type of fat (VF and SF). All 1,002 scans were
segmented by a single individual (KG). This segmentation was
validated by another individual (CS) in 586 scans (VF: r=0.92,
SF: r=0.99).
Pubertal development
Puberty stage (1 to 5) was assessed using Puberty
Development Scale, which is an 8-item self-report measure of
physical development based on Tanner stages [36]. With this
tool, separate forms for males and females are used and the 5
puberty stages (i.e., 1. pre-pubertal, 2. beginning pubertal, 3.
mid-pubertal, 4. advanced pubertal and 5. post-pubertal) are
assessed based on answers to questions regarding pubic hair,
growth in stature, menarche for girls and voice changes in
males. This tool was validated against physician’s assessment
of pubertal development [37] and correlates well with plasma
level of sex hormones [38].
Clinical Measures of Visceral Fat in Adolescence
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Statistical methods
Descriptive statistics used to characterize the study
population included means and standard deviations. Our main
analyses were aimed at estimating the proportion of variance
shared between each of two main clinical measures of
adiposity, namely BMI and waist, and VF or SF. We ran two
sets of multivariable linear regression models, that all adjusted
for inter-individual differences in age and height, and used
either VF or SF as the continuous dependent variable. In the
first sets of analyses, the models that predicted VF did not
adjust for SF, and vice versa, whereas in the second sets of
analyses, they did. The latter sets of analyses were intended to
assess if, and to what extent, BMI and waist predict VF even
among adolescents with the same SF, and vice versa. The
same analytical methods were also employed to examine if VF
and SF can be predicted by suprailiac skinfold and waist/hip,
which are additional anthropometric measures of central
adiposity that could be used in clinical setting. Similar to other
studies [29], marked sex differences in body-fat distribution
were evident in our sample (Table 1). Therefore, we run all our
analyses separately in males and females.”
As secondary analyses, we examined whether pubertal
development influences the observed relationships. To this
end, we added the two-way interactions of puberty stage
(dichotomized as early [stages 1-3] vs. late [stages 4-5]
puberty) with each of the tested main independent variables
(BMI, waist, suprailiac skinfold and waist/hip). Again, these
analyses were carried out in each sex separately.
In preliminary analyses, distributions of all continuous
variables were assessed for the normality assumption on which
the statistical inference about the linear model estimates relies.
The values of variables for which the empirical distribution
showed substantial positive skeweness (normality tested with
K–S statistics), namely BMI, waist, suprailiac skinfold, waist/
hip, VF and SF were all log transformed, using logarithm with
base 10, which improved the fit of the multivariable models in
the main analyses (data not shown).
All statistical analyses were performed using JMP software
(Release 9, SAS Institute Inc., Cary, NC).
Results
Characteristics of studied adolescent males and
females
Mean ages of males (n=482) and females (n=520) differed
by only 1 month, but, as expected [39], males were at an
earlier stage of pubertal development (p<0.0001, Table 1).
Males and females had similar BMI (p=0.75) and VF (p=0.17),
but males (vs. females) showed higher waist (p<0.0001) and
waist/hip (p<0.0001), and lower suprailiac skinfold (p<0.0001)
and SF (p<0.0001, Table 1).
As expected, SF was closely associated with VF; the two
measures shared 77% (p<0.0001) and 64% (p<0.0001) of
variance in males and females, respectively (Figure 1). The
slope of this relationship was steeper in males than females
(p=0.04 for the test of interaction with sex) indicating that, for a
given quantity of SF, males compared with females have more
VF (Figure 1).
Routine clinical measures of adiposity as predictors of
abdominal VF and SF
BMI was closely associated with VF and SF (p<0.0001) in
both sexes; it explained 58% and 55% of variance of VF and
72% and 76% of variance of SF in males and females of the
same age and height, respectively. Relationships of waist with
VF and SF were equally strong (p<0.0001); it explained 61%
(p<0.0001) and 56% (p<0.0001) of variance of VF and 67%
(p<0.0001) and 62% (p<0.0001) of variance of SF in males and
females of the same age and height, respectively (Figure S1 in
File S1).
Table 1. Basic characteristics and adiposity measures of
studied adolescent males and females.
Variables Males Mean ±SD Females Mean ±SD p-value
Number 482 518  
Age (months) 180 ±21 181 ±23 0.18
Height (cm) 167 ±11 160 ±6.7 <0.0001
Puberty stage (1-5) 10/61/184/197/29 3/3/74/296/143 <0.0001
Stage 1 2% 1%  
Stage 2 13% 1%  
Stage 3 38% 14%  
Stage 4 41% 57%  
Stage 5 6% 27%  
Puberty stage (Early/Late) 255/226 83/439 <0.0001
Body mass index    
kg/m2 21.7 ±4.3 21.7 ±4.0 0.87
log kg/m2 1.33 ±0.08 1.33 ±0.08 0.75
percentile 58.8 ±28.8 56.1 ±27.3 0.14
Waist    
cm 75.1 ±10 71.0 ±8.8 <0.0001
log cm 1.87 ±0.06 1.85 ±0.05 <0.0001
Hip    
cm 88.9 ±10 89.9 ±9.9 0.11
log cm 1.95 ±0.05 1.95 ±0.05 0.08
Suprailiac skinfold    
mm 16.8 ±12 20.6 ±10 <0.0001
log mm 1.13 ±0.28 1.26 ±0.21 <0.0001
Waist/hip    
cm/cm 0.848 ±0.056 0.791 ±0.062 <0.0001
log cm/cm -0.073 ±0.028 -0.103 ±0.033 <0.0001
Waist/height    
cm/cm 0.440 ±0.084 0.439 ±0.071 0.88
log cm/cm -0.350 ±0.051 -0.355 ±0.050 0.14
Visceral fat    
cm2 230.49 ±224.98 208.78 ±141.99 0.07
log cm2 2.22 ±0.34 2.24 ±0.25 0.17
Subcutaneous fat    
cm2 1058.57 ±1028.26 1450.07 ±963.33 <0.0001
log cm2 2.86 ±0.36 3.08 ±0.27 <0.0001
Unadjusted mean ± standard deviation for raw and log-transformed values of
relevant characteristics are shown for the studied males and females. P values
indicate statistical significance of differences between males and females
evaluated with 2-sided t test.
doi: 10.1371/journal.pone.0079896.t001
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However, in the models predicting VF adjusted for SF, BMI
and waist explained, respectively, only 0% (p=0.69) and 4%
(p<0.0001) of VF variance (in males); similarly in females, BMI
and waist explained, respectively, just 4% (p<0.0001) and 11%
(p<0.0001) of VF variance (Figure 2). In contrast, in the models
predicting SF adjusted for VF, BMI and waist explained,
respectively, substantial proportions of SF variance - 36%
(p<0.0001) and 21% (p<0.0001) in males and 48% (p<0.0001)
and 23% (p<0.0001) in females (Figure 2). In other words,
among both males and females with the same SF, BMI and
waist did not relate to VF but, among adolescents with the
same VF, these two measures did relate well to SF.
Major changes in body size and composition happen during
puberty, with accelerated weight gain occurring in most boys
Figure 1.  Relationships of VF with SF in adolescent males and females.  A) Magnetic resonance images of analyzed umbilical
slices in 2 individuals with similar subcutaneous fat and different visceral fat. B) Univariate correlations between of VF with SF are
shown in adolescent males and females.
doi: 10.1371/journal.pone.0079896.g001
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and girls at stages 4 and 5 of pubertal development [40].
Therefore, we examined whether the relationships of BMI and
waist with VF and SF differ between adolescents who were in
early puberty (stages 1-3) vs. those who were in late puberty
(stages 4-5, Table S1 in File S1). These analyses showed that
relationships of BMI and waist with VF and SF do not
substantially differ between the two phases of pubertal
development (p>0.30 and p>0.15 for the tests of interaction
with puberty stage in males and females, respectively).
Additional anthropometric measures as predictors of
abdominal VF and SF
In addition to BMI and waist, we investigated two other
anthropometric measures of adiposity that could be used in
clinics as predictors of VF and SF, namely suprailiac skinfold
and waist/hip. Suprailiac skinfold showed strong relationships
with VF and SF in both sexes, explaining 62% (p<0.0001) and
52% (p<0.0001) of VF variance and 72% (p<0.0001) and 64%
(p<0.0001) of SF variance in males and females, respectively
(Figure S2 in File S1). But again, when VF was adjusted for
Figure 2.  BMI and waist circumference as predictors of
VF- and SF-specific quantities (VF and SF adjusted for
each other).  Multivariate linear regression models examining
the relationships of BMI and waist circumference with each VF
and SF (while adjusting for each other) are shown in
adolescent males and females. All relationships were also
adjusted for potentially confounding effects of age and height
when appropriate.
doi: 10.1371/journal.pone.0079896.g002
SF, suprailiac skinfold explained only 2% (p=0.002) and 5%
(<0.001) of VF variance in males and females, respectively,
and when SF was adjusted for VF, it explained 27% (p<0.0001)
and 26% (p<0.0001) of SF variance in males and females,
respectively (Figure S3 in File S1). As such, suprailiac skinfold
compared with BMI and waist showed a similar potential to
predict VF and SF.
Waist/hip, however, demonstrated a different pattern of
relationships. It showed substantially weaker relationships with
both VF or SF (as compared with BMI, waist and suprailiac
skinfold ) – it explained only 22% (p<0.0001) and 20%
(p<0.0001) of VF variance and 12% (p<0.0001) and 6%
(p<0.0001) of SF variance in males and females, respectively
(Figure S2 in File S1). Further, when VF was adjusted for SF,
waist/hip explained 5% (p<0.0001) and 6% (p<0.0001) of VF
variance in males and females, respectively, which was similar
to the other anthropometric measures, but unlike them,
waist/hip explained 0% of variance in both sexes (p=0.81 and
0.33, respectively) when SF was adjusted for VF (Figure S3 in
File S1). As such, waist/hip compared with BMI, waist and
suprailiac skinfold showed a similarly low potential to predict
VF and an even lower potential to predict SF.
The relationships of both these additional anthropometric
measures of adiposity (i.e., suprailiac skinfold and waist/hip)
with VF and SF did not differ between early and late puberty
groups (p>0.29 and p>0.12 for the tests of interaction with
puberty stage in males and females, respectively).
Discussion
The results of the present study demonstrate that, during
adolescence, routine clinical measures of adiposity, namely
BMI and waist, predict SF but not VF. These relationships are
similar in both sexes and exist throughout puberty.
The current study is a large-scale investigation of
adolescents (n=1,002) testing BMI and waist as predictors of
VF and SF measured directly with MRI. A few such (>500
individuals) investigations have been conducted in adults
[41–43] but none in children or adolescents. In the latter age
category (children or adolescents), only smaller-scale studies
have been performed [44–46]. Irrespective of their size or
participants’ age, all of these studies have shown, similarly to
the current one (Figure S1 in File S1), that BMI and waist are
closely related to both VF and SF and explain large proportions
of their respective variances (BMI: 37-69% of VF and 74-89%
of SF; waist: 53-70% of VF and 67-86% of SF) [41–46]. But
because VF and SF are closely associated with each other
(64-77%, Figure 1), it is likely these relationships are driven
mainly by global adiposity. Therefore, in the present study (in
contrast to previous studies [41–45]), we examined how BMI
and waist relate to VF and SF independently of each other –
thus, we examined whether BMI and waist can predict VF- and
SF-specific quantities of body fat. These results showed that
BMI and waist explain a very small proportion of VF-specific
variance (0-11%, Figure 2) but a substantially larger proportion
of SF-specific variance (21-48%, Figure 2), indicating that both
BMI and waist predict mainly SF but not VF.
Clinical Measures of Visceral Fat in Adolescence
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In the present study, we examined two additional
anthropometric measures of adiposity that could be used in
clinics as predictors of VF and SF – these were suprailiac
skinfold and waist/hip. Both measures performed either
similarly or even worse that BMI and waist (Figures S2 and S3
in File S1).
The current study has potential limitations. First, it was
carried out in White Caucasians and its findings may not be
generalizable to other ethnicities. Second, we quantified VF
and SF using a single slice. Single-slice data may not be as
accurate as multi-slice data in quantifying VF volume [47], but
they have been deemed to be a reasonable approximation
[48–50]. Third, we quantified VF and SF at the level of the
umbilicus. This level may be problematic, as it may correspond
to varying locations of the lumbar vertebrae [48,51]. In the
present study, we observed that the umbilicus was located
within a segment of the body that is 5 to 10 cm above the L4/L5
vertebral disk in most our participants (20 out of 20 randomly
selected individuals). VF assessed as a slice area within this
segment has been reported as most closely associated with VF
volume [48,49], as well as with its age-related increases [52]
and risk for CMD [53].
The results of the present large-scale study suggest that, in
adolescence, BMI and waist circumference cannot be used to
estimate VF. This poses a challenge for the practice of
personalized (preventive) medicine, as youth at risk for obesity-
related CMD cannot be easily identified using these clinical
measures [54]. Furthermore, the use of BMI and waist
circumference may obscure our understanding of obesity-
related CMD and thus development of new effective
treatments. As described in Introduction, VF vs. SF is more
closely associated with obesity-related risk for CMD [9–16].
This is because VF vs. SF is more closely located to the portal
circulation [4,20,21] and demonstrates a more adverse
secretory profile [4,17–19]. Further, SF may even be
cardiometabolically protective in overweight and obesity
[14,25,26] due to its “expandability” and thus protection from
the cardiometabolically adverse accumulation of VF [27,28].
Given the clear limitation of currently used clinical measures
of adiposity (BMI and waist circumference) to predict VF,
development of cost-effective imaging techniques to quantify
VF that would be suitable for everyday clinical practice and/or
identification of robust circulating biomarkers of VF
accumulation are warranted.
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